Mass spectrometry in clinical chemistry: The case of newborn screening

Journal of Pharmaceutical and Biomedical Analysis

Volumn 101, Issue , 2014, Pages 174-182

  la Marca, Giancarlo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Clinical chemistry; Inborn errors of metabolism; LC MS MS; Newborn screening; Tandem mass spectrometry

Indexed keywords

BIOLOGICAL MARKER; STEROID;

ACIDEMIA; BLOOD SAMPLING; CLINICAL CHEMISTRY; CLINICAL EVALUATION; CLINICAL EXAMINATION; CONGENITAL ADRENAL HYPERPLASIA; CONGENITAL HYPOTHYROIDISM; COST BENEFIT ANALYSIS; FALSE NEGATIVE RESULT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INBORN ERROR OF METABOLISM; LABORATORY TEST; LYSOSOME STORAGE DISEASE; MASS SPECTROMETRY; MATERNAL DISEASE; METABOLITE; METHYLMALONIC ACIDURIA; NEWBORN; NEWBORN SCREENING; PREDICTIVE VALUE; PREMATURITY; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SCREENING TEST; SEVERE COMBINED IMMUNODEFICIENCY; TANDEM MASS SPECTROMETRY; TREATMENT OUTCOME; CHEMISTRY; DRIED BLOOD SPOT TESTING; PROCEDURES;

BIOLOGICAL MARKERS; CHEMISTRY, CLINICAL; COST-BENEFIT ANALYSIS; DRIED BLOOD SPOT TESTING; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; TANDEM MASS SPECTROMETRY;

EID: 84908338776     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2014.03.047     Document Type: Review

References (56)

1. Guthrie R., Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963, 32:338-343.
2. Millington D.S., Kodo N., Norwood D.L., Roe C.R. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J. Inherit. Metab. Dis. 1990, 13:321-324.
3. la Marca G., Malvagia S., Pasquini E., Innocenti M., Fernandez M.R., Donati M.A., Zammarchi E. The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs. Rapid Commun. Mass Spectrom. 2008, 22:812-818.
4. Turgeon C., Magera M.J., Allard P., Tortorelli S., Gavrilov D., Oglesbee D., Raymond K., Rinaldo P., Matern D. Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots. Clin. Chem. 2008, 54:657-664.
5. Azzari C., la Marca G., Resti M. Neonatal screening for severe combined immunodeficiency caused by an adenosine deaminase defect: a reliable and inexpensive method using tandem mass spectrometry. J. Allergy Clin. Immunol. 2011, 127:1394-1399.
6. la Marca G., Canessa C., Giocaliere E., Romano F., Duse M., Malvagia S., Lippi F., Funghini S., Bianchi L., Della Bona M.L., Valleriani C., Ombrone D., Moriondo M., Villanelli F., Speckmann C., Adams S., Gaspar B.H., Hershfield M., Santisteban I., Fairbanks L., Ragusa G., Resti M., de Martino M., Guerrini R., Azzari C. Tandem mass spectrometry, but not T-cell receptor excision circle analysis, identifies newborns with late-onset adenosine deaminase deficiency. J. Allergy Clin. Immunol. 2013, 131:1604-1610.
7. Speckmann C., Neumann C., Borte S., la Marca G., Sass J.O., Wiech E., Fisch P., Schwarz K., Buchholz B., Schlesier M., Felgentreff K., Grimbacher B., Santisteban I., Bali P., Hershfield M.S., Ehl S. Delayed-onset adenosine deaminase deficiency: strategies for an early diagnosis. J. Allergy Clin. Immunol. 2012, 130:991-994.
8. la Marca G., Giocaliere E., Malvagia S., Funghini S., Ombrone D., Della Bona M.L., Canessa C., Lippi F., Romano F., Guerrini R., Resti M., Azzari C. The inclusion of ADA-SCID in expanded newborn screening by tandem mass spectrometry. J. Pharm. Biomed. Anal. 2014, 88:201-206.
9. Wilson J.M.G., Jungner G. Principles and Practice of Screening for Disease 1968, WHO, Geneva, Available from: http://www.who.int/bulletin/volumes/86/4/07-050112BP.pdf.
10. Loeber J.G., Burgard P., Cornel M.C., Rigter T., Weinreich S.S., Rupp K., Hoffmann G.F., Vittozzi L. Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 1. From blood spot to screening result. J. Inherit. Metab. Dis. 2012, 35(July (4)):603-611.
11. Wilcken B., Wiley V. Newborn screening. Pathology 2008, 40:104-115.
12. Wu L.L., Sazali B.S., Adeeb N., Khalid B.A. Congenital hypothyroid screening using cord blood TSH. Singapore Med. J. 1999, 40:23-26.
13. Abduljabbar M., Al Shahri A., Afifi A. Is umbilical cord blood total thyroxin measurement effective in newborn screening for hypothyroidism?. J. Med. Screen. 2009, 16:119-123.
14. Hardy J.D., Zayed R., Doss I., Dhatt G.S. Cord blood thyroxine and thyroid stimulating hormone screening for congenital hypothyroidism: how useful are they?. J. Pediatr. Endocrinol. Metab. 2008, 21:245-249.
15. Walter J.H., Patterson A., Till J., Besley G.T., Fleming G., Henderson M.J. Bloodspot acylcarnitine and amino acid analysis in cord blood samples: efficacy and reference data from a large cohort study. J. Inherit. Metab. Dis. 2009, 32:95-101.
16. Auray-Blais C., Cyr D., Drouin R. Quebec neonatal mass urinary screening programme: from micromolecules to macromolecules. J. Inherit. Metab. Dis. 2007, 30:515-521.
17. Couce M.L., Castiñeiras D.E., Bóveda M.D., Baña A., Cocho J.A., Iglesias A.J., Colón C., Alonso-Fernández J.R., Fraga J.M. Evaluation and long-term follow-up of infants with inborn errors of metabolism identified in an expanded screening programme. Mol. Genet. Metab. 2011, 104:470-475.
18. Rinaldo P., Zafari S., Tortorelli S., Matern D. Making the case for objective performance metrics in newborn screening by tandem mass spectrometry. Ment. Retard. Dev. Disabil. Res. Rev. 2006, 12:255-261.
19. la Marca G., Malvagia S., Casetta B., Pasquini E., Donati M.A., Zammarchi E. Progress in expanded newborn screening for metabolic conditions by LC-MS/MS in Tuscany: update on methods to reduce false tests. J. Inherit. Metab. Dis. 2008, 31:S395-S404.
20. Chace D.H., Millington D.S., Terada N., Kahler S.G., Roe C.R., Hofman L.F. Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. Clin. Chem. 1993, 39:66-71.
21. Yergey A.L., Liberato D.J., Millington D.S. Thermospray liquid chromatography/mass spectrometry for the analysis of l-carnitine and its short-chain acyl derivatives. Anal. Biochem. 1984, 139:278-283.
22. Millington D.S., Roe C.R., Maltby D.A. Characterization of new diagnostic acylcarnitines in patients with beta-ketothiolase deficiency and glutaric aciduria type I using mass spectrometry. Biomed. Environ. Mass Spectrom. 1987, 14:711-716.
23. Millington D., Kodo N., Terada N., Roe D., Chace D. The analysis of diagnostic markers of genetic disorders in human blood and urine using tandem mass spectrometry with liquid secondary ion mass spectrometry. Int. J. Mass Spectrom. Ion Process. 1991, 111:211-228.
24. Chace D.H. Mass spectrometry in newborn and metabolic screening: historical perspective and future directions. J. Mass Spectrom. 2009, 44:163-170.
25. Chace D.H., Lim T., Hansen C.R., De Jesus V.R., Hannon W.H. Improved MS/MS analysis of succinylacetone extracted from dried blood spots when combined with amino acids and acylcarnitine butyl esters. Clin. Chim. Acta 2009, 407:6-9.
26. la Marca G., Canessa C., Giocalier E., Romano F., Malvagia S., Funghini S., Moriondo M., Valleriani C., Lippi F., Ombrone D., Della Bona M., Speckmann C., Borte S., Brodszki N., Gennery A.R., Weinacht K., Celmeli F., Pagel J., de Martino M., Guerrini R., Wittkowski H., Santisteban I., Bali P., Hershfield M., Notarangelo L.D., Resti M., Azzari C. Diagnosis of immunodeficiency caused by PNP defect using tandem mass spectrometry on dried blood spots. J. Allergy Clin. Immunol. 2014, pii S0091-6749(14)00265-6 [Epub ahead of print]. 10.1016/j.jaci.2014.01.040.
27. Kwan A., Church J.A., Cowan M.J., Agarwal R., Kapoor N., Kohn D.B., Lewis D.B., McGhee S.A., Moore T.B., Stiehm E.R., Porteus M., Aznar C.P., Currier R., Lorey F., Puck J.M. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years. J. Allergy Clin. Immunol. 2013, 132:140-150.
28. Mallott J., Kwan A., Church J., Gonzalez-Espinosa D., Lorey F., Tang L.F., Sunderam U., Rana S., Srinivasan R., Brenner S.E., Puck J. Newborn screening for SCID identifies patients with ataxia telangiectasia. J. Clin. Immunol. 2013, 33:540-549.
29. Spacil Z., Tatipaka H., Barcenas M., Scott C.R., Turecek F., Gelb M.H. High-throughput assay of 9 lysosomal enzymes for newborn screening. Clin. Chem. 2013, 59:502-511.
30. Wolfe B.J., Blanchard S., Sadilek M., Scott C.R., Turecek F., Gelb M.H. Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis II (Hunter syndrome). Anal. Chem. 2011, 83:1152-1156.
31. Khaliq T., Sadilek M., Scott C.R., Turecek F., Gelb M.H. Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis IVA. Clin. Chem. 2011, 57:128-131.
32. Duffey T.A., Sadilek M., Scott C.R., Turecek F., Gelb M.H. Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Anal. Chem. 2010, 82:9587-9591.
33. Blanchard S., Sadilek M., Scott C.R., Turecek F., Gelb M.H. Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis I. Clin. Chem. 2008, 54:2067-2070.
34. Gelb M.H., Turecek F., Scott C.R., Chamole N.A. Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders. J. Inherit. Metab. Dis. 2006, 29:397-404.
35. Ombrone D., Malvagia S., Funghini S., Giocaliere E., Della Bona M.L., Forni G., De Luca A., Villanelli F., Casetta B., Guerrini R., la Marca G. Screening of lysosomal storage disorders: application of the online trapping-and-cleanup liquid chromatography/mass spectrometry method for mucopolysaccharidosis I. Eur. J. Mass Spectrom. 2013, 19:497-503.
36. la Marca G., Casetta B., Malvagia S., Guerrini R., Zammarchi E. New strategy for the screening of lysosomal storage disorders: the use of the online trapping-and-cleanup liquid chromatography/mass spectrometry. Anal. Chem. 2009, 81:6113-6121.
37. Mechtler T.P., Stary S., Metz T.F., De Jesús V.R., Greber-Platzer S., Pollak A., Herkner K.R., Streubel B., Kasper D.C. Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria. Lancet 2012, 379:335-341.
38. Zhang X.K., Elbin C.S., Chuang W.L., Cooper S.K., Marashio C.A., Beauregard C., Keutzer J.M. Multiplex enzyme assay screening of dried blood spots for lysosomal storage disorders by using tandem mass spectrometry. Clin. Chem. 2008, 54:1725-1728.
39. Malvagia S., la Marca G., Casetta B., Gasperini S., Pasquini E., Donati M.A., Zammarchi E. Falsely elevated C4-carnitine as expression of glutamate formiminotransferase deficiency in tandem mass spectrometry newborn screening. J. Mass Spectrom. 2006, 41:263-265.
40. Stadler S.C., Polanetz R., Maier E.M., Heidenreich S.C., Niederer B., Mayerhofer P.U., Lagler F., Koch H.G., Santer R., Fletcher J.M., Ranieri E., Das A.M., Spiekerkötter U., Schwab K.O., Pötzsch S., Marquardt I., Hennermann J.B., Knerr I., Mercimek-Mahmutoglu S., Kohlschmidt N., Liebl B., Fingerhut R., Olgemöller B., Muntau A.C., Roscher A.A., Röschinger W. Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment. Hum. Mutat. 2006, 27:748-759.
41. Bodamer O.A., Hoffmann G.F., Lindner M. Expanded newborn screening in Europe 2007. J. Inherit. Metab. Dis. 2007, 30:439-444.
42. Grünert S.C., Stucki M., Morscher R.J., Suormala T., Bürer C., Burda P., Christensen E., Ficicioglu C., Herwig J., Kölker S., Möslinger D., Pasquini E., Santer R., Schwab K.O., Wilcken B., Fowler B., Yue W.W., Baumgartner M.R. 3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals. Orphanet J. Rare Dis. 2012, 7:31.
43. Nizon M., Ottolenghi C., Valayannopoulos V., Arnoux J.B., Barbier V., Habarou F., Desguerre I., Boddaert N., Bonnefont J.P., Acquaviva C., Benoist J.F., Rabier D., Touati G., de Lonlay P. Long-term neurological outcome of a cohort of 80 patients with classical organic acidurias. Orphanet J. Rare Dis. 2013, 8:148-160.
44. Tan E.S., Wiley V., Carpenter K., Wilcken B. Non-ketotic hyperglycinemia is usually not detectable by tandem mass spectrometry newborn screening. Mol. Genet. Metab. 2007, 90:446-448.
45. Ciani F., Pasquini E., Ciardetti A., Donati M.A., Zammarchi E. Hyperglycinemia in clinical-laboratory practice. Pediatr. Med. Chir. 1997, 19:109-112.
46. Chace D.H., Hannon W.H. Clin. Chem. 2010, 56:1653-1655.
47. Calvin J., Hogg S.L., McShane D., McAuley S.A., Iles R., Ross-Russell R., MacLean F.M., Heeley M.E., Heeley A.F. Norfolk, Suffolk and Cambridgeshire paediatric cystic fibrosis network. Arch. Dis. Child. 2012, 97:1043-1047.
48. Seo J.Y., Park H.D., Kim J.W., Oh H.J., Yang J.S., Chang Y.S., Park W.S., Lee S.Y. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation. J. Perinat. Med. 2014, 42:121-127.
49. Al-Dirbashi O.Y., Rashed M.S., Jacob M., Al-Ahaideb L.Y., Al-Amoudi M., Rahbeeni Z., Al-Sayed M.M., Al-Hassnan Z., Al-Owain M., Al-Zeidan H. Biomed. Chromatogr. 2008, 22:1181-1185.
50. la Marca G., Malvagia S., Funghini S., Pasquini E., Moneti G., Guerrini R., Zammarchi E. The successful inclusion of succinylacetone as a marker of tyrosinemia type I in Tuscany newborn screening program. Rapid Commun. Mass Spectrom. 2009, 23:3891-3893.
51. la Marca G., Malvagia S., Pasquini E., Innocenti M., Donati M.A., Zammarchi E. Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry. Clin. Chem. 2007, 53:1364-1369.
52. Cloppenborg T., Janzen N., Wagner H., Steuerwald U., Peter M., Das A. Application of a second-tier newborn screening assay for C5 isoforms. JIMD Rep. 2013.
53. Fu X., Xu Y.K., Chan P., Pattengale P.K. Simple, fast, and simultaneous detection of plasma total homocysteine, methylmalonic acid, methionine, and 2-methylcitric acid using liquid chromatography and mass spectrometry (LC/MS/MS). JIMD Rep. 2013, 10:69-78.
54. Wang C., Zhu H., Zhang W., Song F., Liu Z., Liu S. Second-tier test for quantification of underivatized amino acids in dry blood spot for metabolic diseases in newborn screening. Amino Acids 2013, 44:661-671.
55. Gucciardi A., Pirillo P., Di Gangi I.M., Naturale M., Giordano G. A rapid UPLC-MS/MS method for simultaneous separation of 48 acylcarnitines in dried blood spots and plasma useful as a second-tier test for expanded newborn screening. Anal. Bioanal. Chem. 2012, 404:741-751.
56. Alodaib A., Carpenter K., Wiley V., Sim K., Christodoulou J., Wilcken B. An improved ultra performance liquid chromatography-tandem mass spectrometry method for the determination of alloisoleucine and branched chain amino acids in dried blood samples. Ann. Clin. Biochem. 2011, 48:468-470.